Reducing Financial Toxicity in Oncology Requires Earlier Screening, Payer-Provider Collaboration: Scott Soefje, PharmD, MBA, BCOP
Scott Soefje, PharmD, outlines proactive financial screening, flexible payment models, and stronger academic-community partnerships for advanced cancer care.
Balancing Innovation, Access, and Affordability in Oncology: Scott Soefje, PharmD, MBA, BCOP
Scott Soefje, PharmD, MBA, BCOP, of Mayo Clinic, discusses how payer-provider collaboration and pharmacist-led management can help improve oncology care.
Neulasta Onpro: A Coup de Grâce?
With the rapid decline in average sales price of reference pegfilgrastim products due to biosimilar competition, health care institutions and payers may grapple with coverage of Neulasta Onpro.
